Biogen Inc. (NASDAQ:BIIB) ranks among the most undervalued NASDAQ stocks to buy now. On September 18, Biogen Inc. (NASDAQ:BIIB) announced that it had finalized a deal to acquire Alcyone Therapeutics for an initial cash payment of $85 million and milestone payments. The acquisition focuses on the ThecaFlex DRx, an implantable subcutaneous port and catheter device that is being researched for antisense oligonucleotide (ASO) intrathecal delivery. The system is intended to give patients with neurological ill ...

Biogen (NASDAQ:BIIB) said that it has agreed to acquire Alcyone Therapeutics, a company based in Massachusetts. The deal involves an upfront payment of $85M, along with additional milestone payments tied to the development and regulatory approval of ThecaFlex DRx, which is associated with ...